Black Diamond Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $465k | 123k | 3.79 |
| 2025-06-30 | $595k | 240k | 2.48 |
| 2024-06-30 | $78k | 17k | 4.64 |
| 2022-09-30 | $38k | 23k | 1.69 |
| 2021-09-30 | $586k | 69k | 8.46 |
| 2021-06-30 | $888k | 73k | 12.19 |
| 2021-03-31 | $514k | 21k | 24.25 |